Meningoccocal Disease

1

Review clinical trials related to Meningoccocal Disease. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Evaluation of the Antibody Persistence Beyond Five Years After Immunization With MenFiveTM (NmCV-5), a Pentavalent Meningococcal ACYWX Conjugate Vaccine

This study will measure immune persistence of the NmCV-5 more than 5 years after a single dose vaccination in participants 2-29 years of age in Mali and The Gambia.

Participants needed: 450
Trial details
Age: 7-36Biological sex: AllType: ObservationalSponsor: Serum Institute of India Pvt. Ltd.Updated: Jun 3, 2026Locations: 2Duration: 1 Day
Eligibility criteria

Written informed consent and assent (if applicable)

Current or previous, confirmed disease caused by Neisseria meningitidis at any g... [+1]